by David Kent | Feb 6, 2018
In my last post, I drew our readers’ attention to an excellent article by Giulio Cossu and colleagues on stem cells and regenerative medicine where the authors set out a number of recommendations for the regenerative medicine field. One of those recommendations was...
by Sara M. Nolte | Jan 15, 2018
With the start of a new year, I like to take a moment to think about what things in cancer research got me really excited the previous year. Beyond a doubt, that thing for me in 2017 was the first (and second!) FDA approval of a CAR T-cell (chimeric antigen receptor...
by Nicole Kuchinsky | Dec 5, 2017
One of my personal highlights from this year’s Till and McCulloch Meetings was attending the “Science for Citizens” panel (reported on in a previous post). Experts including Timothy Caulfield, patient advocate William Brock, and National Post writer Tom...
by Stacey Johnson | Nov 24, 2017
Happy Thanksgiving to our American family, friends and colleagues. It may feel like 2017 didn’t offer quite as much to be thankful for on a global level, but there was one uplifting international event that rocked our world. Despacito. On January 12, 2017, Universal...
by Hamideh Emrani | Nov 9, 2017
Another interesting talk, on the first morning of the Canadian Till & McCulloch Meetings, was from Dr. Bruce Verchere who spoke about possible routes to prevent graft rejection in the case of human β-cell and islet cell transplants for diabetes through...
by Hamideh Emrani | Nov 8, 2017
This year’s Till & McCulloch Meetings began with a rainy day on the beautiful mountainside in Mont-Tremblant, Quebec. The morning talks started off with Dr. Matthias Lütolf. His lab at the École Polytechnique Fédérale de Lausanne, (EPFL) works on strategies to...
Comments